Plantarc Bio Ltd. Logo

Plantarc Bio Ltd.

Developing high-yield, resilient crops via gene discovery for global seed companies.

PLNT | TA

Overview

Corporate Details

ISIN(s):
IL0011714040
LEI:
Country:
Israel
Address:
Birkat Am St 61-63, 4390500 Giv’at Hen
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Plantarc Bio Ltd. is an agricultural biotechnology company focused on enhancing global food security through genetic technology. The company specializes in gene discovery and the development of RNAi-based products to improve crop performance and sustainability. It utilizes its proprietary Direct-In-Plant (DIP™) platform for gene discovery and the DIPPER™ platform for gene-editing optimization. Plantarc Bio's key development areas include increasing crop yield, improving drought resistance, and creating herbicide and insect tolerance. The company collaborates with global seed companies to develop and commercialize enhanced traits for major crops such as soybeans, canola, rice, and sugarcane.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2023-03-14 11:09
Investor Presentation
Presentation-World Agri-Tech Innovation Summit
English 9.4 MB
2023-03-14 11:09
Regulatory News Service
Presentation-World Agri-Tech Innovation Summit
Russian 43.3 KB
2022-01-27 14:21
Regulatory News Service
Plantarc – Appointment of a Market Maker, will not be included in the illiquid …
Hebrew (modern) 256.9 KB
2021-01-06 15:29
Regulatory News Service
On Thursday, 7 January 2021, trading will commence in the following Security: P…
Hebrew (modern) 174.5 KB
2021-01-04 17:13
Regulatory News Service
Identifying Details of New Security -PLANT ARC, PLANT ARC W1
Hebrew (modern) 178.5 KB
2020-11-18 16:16
Investor Presentation
Investor Presentation
English 1.8 MB
2020-11-18 16:16
Pre-Annual General Meeting Information
Investor Presentation
Russian 42.7 KB

Automate Your Workflow. Get a real-time feed of all Plantarc Bio Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Plantarc Bio Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Plantarc Bio Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Open Up Group Inc. Logo
Provides staffing and outsourcing of engineers for global manufacturing, IT, and construction sectors.
Japan 2154
Optipharm.CO.,LTD Logo
Biotech for animal health and xenotransplantation using genetically engineered pig organs.
South Korea 153710
Organoid-based platforms for drug testing and regenerative therapeutics.
South Korea 476040
Oricon Inc. Logo
Provides entertainment industry data, music charts, web media, and marketing services.
Japan 4800
ORIENTBIO Inc. Logo
Provides animal models & technical services for preclinical R&D to pharma & research institutions.
South Korea 002630
Oryzon Genomics S.A. Logo
Develops epigenetic-based medicines for cancer and central nervous system disorders.
Spain ORY
OSCOTECInc. Logo
A clinical-stage drug discovery company developing innovative medicines for unmet needs.
South Korea 039200
OSE Immunotherapeutics Logo
Develops first-in-class immune therapies for oncology and inflammation, partnering for late-stage.
France OSE
Oxurion NV Logo
Acquires European pharmaceutical subcontractors to build an integrated healthcare services group.
Belgium OXUR
PA Co., Ltd Logo
Offers HR solutions like recruitment media, staffing, and childcare to revitalize local communities.
Japan 4766

Talk to a Data Expert

Have a question? We'll get back to you promptly.